Regulatory mechanism of matrix metalloprotease-2 enzymatic activity by factor Xa and thrombin

Bon-Hun Koo1, Michael Y Park, Ok-Hee Jeon

  • 1National Research Laboratory, Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, 134 Sinchon-Dong Seodaemun-Gu, Seoul 120-749, Korea.

Insights

Factor Xa and thrombin activate matrix metalloprotease (MMP)-2 independently of MT1-MMP and also degrade it, balancing MMP-2 activity.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Enzymology

Background:

  • Matrix metalloprotease (MMP)-2 is crucial for cell migration and invasion.
  • MMP-2 activation typically involves propeptide cleavage, with MT1-MMP being a well-studied activator.
  • Serine protease roles in MMP-2 activation are less understood, though MT1-MMP involvement is suggested.

Purpose of the Study:

  • To investigate the role of factor Xa and other serine proteases in pro-MMP-2 activation.
  • To elucidate the specific cleavage sites and mechanisms of activation and degradation by serine proteases.
  • To understand how these processes regulate net MMP-2 enzymatic activity.

Main Methods:

  • Investigated pro-MMP-2 processing by factor Xa, thrombin, and plasmin in vascular smooth muscle and endothelial cells.
  • Determined specific cleavage sites within the propeptide using biochemical assays.
  • Assessed the enzymatic activity of processed MMP-2 and its regulation by autoproteolysis and degradation.

Main Results:

  • Factor Xa directly cleaved pro-MMP-2 independently of MT1-MMP at Arg(98) and Arg(101).
  • Thrombin and plasmin also processed pro-MMP-2, with distinct cleavage patterns.
  • Processed MMP-2 exhibited enhanced activity via autoproteolysis, and factor Xa/thrombin regulated its activity through both activation and degradation.

Conclusions:

  • Factor Xa and thrombin are novel activators of MMP-2, mediating MT1-MMP-independent processing.
  • These serine proteases regulate MMP-2 activity by balancing its activation and degradation.
  • The net enzymatic activity of MMP-2 is determined by the interplay between its activation and degradation pathways.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...